VU0357017
VU0357017 (CID-25010775) is a potent, selective and brain-penetrant allosteric agonist of M1 muscarinic acetylcholine receptor, with an EC50 of 477 nM. VU0357017 is highly selective for M1 and has no activity at M2-M5 up to the highest concentrations tested (30 μM). VU0357017 can be used for the research of Alzheimer’s disease and schizophrenia.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1135681-23-0
- Formule: C18H27N3O3
- Masse moléculaire:333.43
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | EC50 |
>30 μM
Compound: 8, ML071, VU0357017
|
Agonist activity at rat muscarinic M2 receptor expressed in CHO cells
Agonist activity at rat muscarinic M2 receptor expressed in CHO cells
|
[PMID: 21930376] |
| CHO | EC50 |
>30 μM
Compound: 8, ML071, VU0357017
|
Agonist activity at rat muscarinic M3 receptor expressed in CHO cells
Agonist activity at rat muscarinic M3 receptor expressed in CHO cells
|
[PMID: 21930376] |
| CHO | EC50 |
>30 μM
Compound: 8, ML071, VU0357017
|
Agonist activity at rat muscarinic M4 receptor expressed in CHO cells
Agonist activity at rat muscarinic M4 receptor expressed in CHO cells
|
[PMID: 21930376] |
| CHO | EC50 |
>30 μM
Compound: 8, ML071, VU0357017
|
Agonist activity at rat muscarinic M5 receptor expressed in CHO cells
Agonist activity at rat muscarinic M5 receptor expressed in CHO cells
|
[PMID: 21930376] |
| CHO | EC50 |
0.2 μM
Compound: 8, ML071, VU0357017
|
Agonist activity at rat muscarinic M1 receptor expressed in CHO cells
Agonist activity at rat muscarinic M1 receptor expressed in CHO cells
|
[PMID: 21930376] |
Chemical Information
-
CAS No. 1135681-23-0
-
Masse moléculaire 333.43
-
Formule C18H27N3O3
-
SMILES
O=C(N1CCC(NCCNC(C2=CC=CC=C2C)=O)CC1)OCC
-
Synonyms
CID-25010775 free base
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Digby GJ, et al. Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding mode. ACS Chem Neurosci. 2012 Dec 19;3(12):1025-36. [Content Brief]
[2]. Lebois EP, et al. Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system. ACS Chem Neurosci. 2010;1(2):104-121. [Content Brief]
[3]. Digby GJ, et al. Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models. J Neurosci. 2012 Jun 20;32(25):8532-44. [Content Brief]
[4]. Sheffler DJ, et al. Further exploration of M? allosteric agonists: subtle structural changes abolish M? allosteric agonism and result in pan-mAChR orthosteric antagonism. Bioorg Med Chem Lett. 2013 Jan 1;23(1):223-7. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)